体外诊断试剂市场－全球产业规模、份额、趋势、机会和预测，按类型、技术、用途、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球体外诊断（IVD）试剂市场规模为787.5亿美元，预计2030年将以5.35%的复合年增长率成长至1,076.6亿美元。体外诊断（IVD）试剂是用于体外检测的生化或生物物质，透过分析患者样本，实现疾病的检测、诊断、监测和治疗。全球IVD试剂市场呈现强劲成长势头，主要得益于慢性病和传染病在全球日益普遍，以及对个人化医疗需求的不断增长，而这又需要高度特异性的诊断解决方案。对准确及时的诊断资讯的持续需求，是推动市场持续扩张的根本原因。

主要市场驱动因素

全球慢性病和传染病的日益普及是体外诊断试剂发展的主要驱动因素。癌症、糖尿病、心血管疾病和新出现的传染病病原体等疾病需要持续、广泛的诊断检测，以进行筛检、准确诊断和疾病管理。

主要市场挑战

繁琐的监管要求严重阻碍了全球体外诊断（IVD）试剂市场的成长。复杂的认证流程和漫长的审批时间限制了新诊断产品的及时上市和供应。

主要市场趋势

向分散式和即时检测（POC​​）的转变正在拓展诊断能力，使其超越传统实验室环境，让检测更贴近患者，并有助于更及时地做出临床决策。这一趋势要求开发稳定可靠、易于使用且与小型便携式设备相容的试剂配方。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球体外诊断（IVD）试剂市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型（抗体、纯化蛋白质和胜肽、寡核苷酸、其他）
  • 依技术分类（免疫测定、临床化学、分子诊断、微生物学、血液学、其他）
  • 依用途分类（临床用途、研究用途、其他）
  • 按最终用户划分（体外诊断试剂生产商、学术机构和研究实验室、医院实验室、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美体外诊断（IVD）试剂市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲体外诊断（IVD）试剂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区体外诊断试剂市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲体外诊断（IVD）试剂市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲体外诊断（IVD）试剂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球体外诊断（IVD）试剂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Thermo Fisher Scientific Inc
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc
• Agilent Technologies, Inc.
• QIAGEN NV
• Merck KGaA
• Beckman Coulter, Inc
• Hologic, Inc
• Abcam Ltd
• Bio-Techne Corp

第十六章：策略建议

第17章调查会社について・免责事项

The Global In Vitro Diagnostic (IVD) Reagents Market, valued at USD 78.75 Billion in 2024, is projected to experience a CAGR of 5.35% to reach USD 107.66 Billion by 2030. In vitro diagnostic (IVD) reagents are biochemical or biological substances essential for tests conducted outside the human body, enabling the detection, diagnosis, monitoring, and treatment of diseases by analyzing patient samples. The global IVD reagents market demonstrates robust growth, primarily supported by the increasing worldwide prevalence of chronic and infectious diseases, coupled with a rising demand for personalized medicine which necessitates highly specific diagnostic solutions. This consistent requirement for accurate and timely diagnostic information underpins the sustained expansion of the market.

Key Market Drivers

The escalating global prevalence of chronic and infectious diseases is a primary driver for in vitro diagnostic reagents. Conditions such as cancer, diabetes, cardiovascular diseases, and emerging infectious pathogens necessitate continuous and extensive diagnostic testing for screening, accurate diagnosis, and disease management. This persistent need directly increases the consumption of IVD reagents across diverse diagnostic platforms. For example, the substantial global cancer burden underscores this demand.

Key Market Challenges

The extensive regulatory requirements significantly impede the growth of the Global In Vitro Diagnostic (IVD) Reagents Market. The complex certification processes and lengthy timelines restrict the timely introduction and availability of new diagnostic products. For example, according to a MedTech Europe survey in 2024, the choice of the EU as the first launch geography for IVD large manufacturers dropped by 40% due to regulatory burdens, indicating a diversion of innovation away from this critical market. This directly translates to fewer innovative reagents reaching patients and healthcare providers, thus limiting market expansion.

Key Market Trends

The shift towards decentralized and point-of-care (POC) testing is expanding diagnostic capabilities beyond traditional laboratory settings, bringing testing closer to patients and facilitating more immediate clinical decisions. This trend necessitates the development of robust, user-friendly reagent formulations compatible with smaller, often portable devices. Such decentralization is crucial for improving access to timely diagnostics, particularly in remote areas or emergency situations.

Key Market Players

• Thermo Fisher Scientific Inc
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc
• Agilent Technologies, Inc.
• QIAGEN N.V.
• Merck KGaA
• Beckman Coulter, Inc
• Hologic, Inc
• Abcam Ltd
• Bio-Techne Corp

Report Scope:

In this report, the Global In Vitro Diagnostic (IVD) Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In Vitro Diagnostic (IVD) Reagents Market, By Type:

• Antibodies
• Purified Proteins and Peptides
• Oligonucleotides
• Others

In Vitro Diagnostic (IVD) Reagents Market, By Technology:

• Immunoassay
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Hematology
• Others

In Vitro Diagnostic (IVD) Reagents Market, By Use:

• Clinical Use
• Research Use
• Others

In Vitro Diagnostic (IVD) Reagents Market, By End User:

• IVD Manufacturers
• Academic Institutes & Research Laboratories
• Hospital Laboratories
• Others

In Vitro Diagnostic (IVD) Reagents Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In Vitro Diagnostic (IVD) Reagents Market.

Available Customizations:

Global In Vitro Diagnostic (IVD) Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In Vitro Diagnostic (IVD) Reagents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others)
  • 5.2.2. By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others)
  • 5.2.3. By Use (Clinical Use, Research Use, Others)
  • 5.2.4. By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America In Vitro Diagnostic (IVD) Reagents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Use
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Use
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Use
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Use
      • 6.3.3.2.4. By End User

7. Europe In Vitro Diagnostic (IVD) Reagents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Use
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Use
      • 7.3.1.2.4. By End User
  • 7.3.2. France In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Use
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Use
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Use
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Use
      • 7.3.5.2.4. By End User

8. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Use
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Use
      • 8.3.1.2.4. By End User
  • 8.3.2. India In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Use
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Use
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Use
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Use
      • 8.3.5.2.4. By End User

9. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Use
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Use
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Use
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Use
      • 9.3.3.2.4. By End User

10. South America In Vitro Diagnostic (IVD) Reagents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Use
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Use
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Use
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Use
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global In Vitro Diagnostic (IVD) Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. Bio-Rad Laboratories, Inc
• 15.4. Agilent Technologies, Inc.
• 15.5. QIAGEN N.V.
• 15.6. Merck KGaA
• 15.7. Beckman Coulter, Inc
• 15.8. Hologic, Inc
• 15.9. Abcam Ltd
• 15.10. Bio-Techne Corp

16. Strategic Recommendations

17. About Us & Disclaimer